tedizolid and Tuberculosis--Multidrug-Resistant

tedizolid has been researched along with Tuberculosis--Multidrug-Resistant* in 1 studies

Other Studies

1 other study(ies) available for tedizolid and Tuberculosis--Multidrug-Resistant

Article	Year
In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics. Diagnostic microbiology and infectious disease, 2022, Volume: 103, Issue:3 The effects of tedizolid (TZD) against multidrug-resistant Mycobacterium tuberculosis isolates were investigated. This is possibly the first study to evaluate the MIC of TZD against Japanese Mycobacterium tuberculosis isolates. As TZD had a significantly lower MIC than LZD (P < 0.01), it was suggested to be a better, non-toxic alternative to LZD. Topics: Anti-Bacterial Agents; Genomics; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tetrazoles; Tuberculosis, Multidrug-Resistant	2022

Article

Year

In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics.

Diagnostic microbiology and infectious disease, 2022, Volume: 103, Issue:3

The effects of tedizolid (TZD) against multidrug-resistant Mycobacterium tuberculosis isolates were investigated. This is possibly the first study to evaluate the MIC of TZD against Japanese Mycobacterium tuberculosis isolates. As TZD had a significantly lower MIC than LZD (P < 0.01), it was suggested to be a better, non-toxic alternative to LZD.

Topics: Anti-Bacterial Agents; Genomics; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tetrazoles; Tuberculosis, Multidrug-Resistant

2022